Literature DB >> 21921145

Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury.

Gunnar Schley1, Bernd Klanke, Johannes Schödel, Frauke Forstreuter, Deepa Shukla, Armin Kurtz, Kerstin Amann, Michael S Wiesener, Seymour Rosen, Kai-Uwe Eckardt, Patrick H Maxwell, Carsten Willam.   

Abstract

Hypoxia-inducible transcription factors (HIF) protect cells against oxygen deprivation, and HIF stabilization before ischemia mitigates tissue injury. Because ischemic acute kidney injury (AKI) often involves the thick ascending limb (TAL), modulation of HIF in this segment may be protective. Here, we generated mice with targeted TAL deletion of the von Hippel-Lindau protein (Vhl), which mediates HIF degradation under normoxia, using Tamm-Horsfall protein (Thp)-driven Cre expression. These mice showed strong expression of HIF-1α in TALs but no changes in kidney morphology or function under control conditions. Deficiency of Vhl in the TAL markedly attenuated proximal tubular injury and preserved TAL function following ischemia-reperfusion, which may be partially a result of enhanced expression of glycolytic enzymes and lactate metabolism. These results highlight the importance of the thick ascending limb in the pathogenesis of AKI and suggest that pharmacologically targeting the HIF system may have potential to prevent and mitigate AKI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921145      PMCID: PMC3279994          DOI: 10.1681/ASN.2010121249

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  69 in total

Review 1.  Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable.

Authors:  W Lieberthal; S K Nigam
Journal:  Am J Physiol Renal Physiol       Date:  2000-01

2.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.

Authors:  Kuniko Kimura; Masayuki Iwano; Debra F Higgins; Yukinari Yamaguchi; Kimihiko Nakatani; Koji Harada; Atsushi Kubo; Yasuhiro Akai; Erinn B Rankin; Eric G Neilson; Volker H Haase; Yoshihiko Saito
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

7.  The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors.

Authors:  Christina Warnecke; Alexander Weidemann; Melanie Volke; Ruth Schietke; Xiaoqing Wu; Karl X Knaup; Thomas Hackenbeck; Wanja Bernhardt; Carsten Willam; Kai-Uwe Eckardt; Michael S Wiesener
Journal:  Exp Cell Res       Date:  2008-03-18       Impact factor: 3.905

8.  Apoptosis of the thick ascending limb results in acute kidney injury.

Authors:  Manakan B Srichai; Chuanming Hao; Linda Davis; Anastasia Golovin; Min Zhao; Gilbert Moeckel; Steve Dunn; Nada Bulus; Raymond C Harris; Roy Zent; Matthew D Breyer
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

9.  pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation.

Authors:  Ian J Frew; Claudio R Thoma; Strahil Georgiev; Andrea Minola; Manuela Hitz; Matteo Montani; Holger Moch; Wilhelm Krek
Journal:  EMBO J       Date:  2008-05-22       Impact factor: 11.598

Review 10.  Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury.

Authors:  Wanja M Bernhardt; Kai-Uwe Eckardt
Journal:  Curr Opin Crit Care       Date:  2008-12       Impact factor: 3.687

View more
  47 in total

1.  Inducible glomerular erythropoietin production in the adult kidney.

Authors:  Katharina Gerl; Lucile Miquerol; Vladimir T Todorov; Christian P M Hugo; Ralf H Adams; Armin Kurtz; Birgül Kurt
Journal:  Kidney Int       Date:  2015-09-23       Impact factor: 10.612

Review 2.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

3.  Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.

Authors:  Bjoern Buchholz; Gunnar Schley; Diana Faria; Sven Kroening; Carsten Willam; Rainer Schreiber; Bernd Klanke; Nicolai Burzlaff; Jonathan Jantsch; Karl Kunzelmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 4.  Novel roles for mucin 1 in the kidney.

Authors:  Mohammad M Al-Bataineh; Timothy A Sutton; Rebecca P Hughey
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-09       Impact factor: 2.894

Review 5.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

6.  Ferulic Acid Protected from Kidney Ischemia Reperfusion Injury in Mice: Possible Mechanism Through Increasing Adenosine Generation via HIF-1α.

Authors:  Qin Zhou; Xia Gong; Ge Kuang; Rong Jiang; Tianjun Xie; HongTao Tie; XiaHong Chen; Ke Li; JingYuan Wan; Bin Wang
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

7.  Lipid Peroxidation Drives Renal Cyst Growth In Vitro through Activation of TMEM16A.

Authors:  Rainer Schreiber; Björn Buchholz; Andre Kraus; Gunnar Schley; Julia Scholz; Jiraporn Ousingsawat; Karl Kunzelmann
Journal:  J Am Soc Nephrol       Date:  2019-01-03       Impact factor: 10.121

8.  Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury.

Authors:  Joshua A Smith; L Jay Stallons; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-02

Review 9.  Innate immunity in donor procurement.

Authors:  Kitty P Cheung; Sashi G Kasimsetty; Dianne B McKay
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

10.  Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway.

Authors:  Tomoo Osumi; Midori Awazu; Eriko Fujimura; Fumito Yamazaki; Akinori Hashiguchi; Hiroyuki Shimada
Journal:  Eur J Pediatr       Date:  2013-05-16       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.